Last reviewed · How we verify
Placebo for Cannabis
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the patient's expectation and psychological response.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the patient's expectation and psychological response. Used for Control arm in cannabis efficacy and safety trial.
At a glance
| Generic name | Placebo for Cannabis |
|---|---|
| Sponsor | University of Colorado, Denver |
| Modality | Small molecule |
| Therapeutic area | Neurology/Psychiatry |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to measure the effect of patient expectation, belief, and the therapeutic context independent of any pharmacological action. In this Phase 3 trial for cannabis, the placebo serves as a comparator to isolate the true pharmacological effects of cannabis from placebo response effects. The placebo effect can involve neurobiological mechanisms including endogenous opioid release, dopamine activation, and other central nervous system changes triggered by expectation.
Approved indications
- Control arm in cannabis efficacy and safety trial
Common side effects
Key clinical trials
- Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream (EARLY_PHASE1)
- N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use (PHASE4)
- Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment (PHASE2)
- Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (PHASE2)
- Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden (PHASE2)
- Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain (NA)
- Drug-Drug Interaction Between THC and AEF0117 (PHASE1)
- Repeated CBD Administration and Cannabis Outcomes (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for Cannabis CI brief — competitive landscape report
- Placebo for Cannabis updates RSS · CI watch RSS
- University of Colorado, Denver portfolio CI